Cited by 288Prostate Cancer Treatment and ResearchEstrogen and related hormone effectsSperm and Testicular Function

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Open access

Zhu, M.-L., Kyprianou, N.·2008·Endocrine Related Cancer

Open this paper in CoChat — free account Open PDF

Abstract

Androgens promote the growth and differentiation of prostate cells through ligand activation of the androgen receptor (AR). Sensitization of the androgenic response by multifunctional growth factor signaling pathways is one of the mechanisms via which AR contributes to the emergence of androgen-independent prostate tumors. The ability of AR to cross-talk with key growth factor signaling events toward the regulation of cell cycle, apoptosis, and differentiation outcomes in prostate cancer cells is established. In this paper, we review the functional interaction between AR and an array of growth factor signal transduction events (including epidermal growth factor; fibroblast growth factor; IGF1; vascular endothelial growth factor; transforming growth factor-beta) in prostate tumors. The significance of this derailed cross-talk between androgens and key signaling networks in prostate cancer progression and its value as a therapeutic forum targeting androgen-independent metastatic prostate cancer is discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1677/erc-08-0084

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U., Liotta, L. A., Falanga, V., & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,867
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Molecular and cellular endocrinology
(1995) · Journal of Endocrinology · doi:10.1677/joe.0.147so19 · Cited by 1,986
Fibroblast growth factors.
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 1,985
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,628
A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
Craft, N., Shostak, Y., Carey, M., & Sawyers, C. L. (1999) · Nature Medicine · doi:10.1038/6495 · Cited by 980
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Transforming growth factor-beta: recent progress and new challenges.
Sporn, M. B., & Roberts, A. B. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.5.1017 · Cited by 760
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
Fatty Acid Synthase and Cancer: New Application of an Old Pathway
Kuhajda, F. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4673 · Cited by 654
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1 · Cited by 624
From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells
Yeh, S., Lin, H., Kang, H., Thin, T. H., Lin, M., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5458 · Cited by 594
Testosterone Formation and Metabolism During Male Sexual Differentiation in the Human Embryo
Siiteri, P. K., & Wilson, J. D. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-1-113 · Cited by 591
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergström, R., Signorello, L. B., Λάγιου, Π., Adami, H., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 568
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
Grossmann, M. E., Huang, H., & Tindall, D. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1687 · Cited by 548
Immunohistochemical Localization of the Androgen Receptor in Rat and Human Tissues*
Sar, M., Lubahn, D. B., French, F. S., & Wilson, E. M. (1990) · Endocrinology · doi:10.1210/endo-127-6-3180 · Cited by 489
Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer.
Lorenzo, G. D., Tortora, G., D’Armiento, F. P., Rosa, G. D., Staibano, S., Riccardo Autorino, B., D’Armiento, M., Laurentiis, M. D., Placido, S. D., Catalano, G., et al. (2002) · PubMed · Cited by 474
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.
Gleave, M. E., Hsieh, J., Gao, C. A., von Eschenbach, A. C., & Chung, L. W. K. (1991) · PubMed · Cited by 452
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor.
Hobisch, A., Eder, I. E., Putz, T., Horninger, W., Bartsch, G. C., Klocker, H., & Čulig, Z. (1998) · PubMed · Cited by 437
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.
Camps, J. L., Chang, S. M., Hsu, T., Freeman, M. R., Hong, S. J., Zhau, H. E., von Eschenbach, A. C., & Chung, L. W. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.75 · Cited by 416
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.
Mellinghoff, I. K., Vivanco, I., Kwon, A., Tran, C., Wongvipat, J., & Sawyers, C. L. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.031 · Cited by 344
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells.
Ueda, T., Mawji, N. R., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203313200 · Cited by 311
Rapid signalling by androgen receptor in prostate cancer cells
Peterziel, H., Mink, S., Schonert, A., Becker, M., Klocker, H., & Cato, A. C. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203032 · Cited by 269
Stat3 Promotes Metastatic Progression of Prostate Cancer
Abdulghani, J., Gu, L., Dagvadorj, A., Lutz, J., Leiby, B. E., Bonuccelli, G., Lisanti, M. P., Zellweger, T., Alanen, K. A., Mirtti, T. K., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071054 · Cited by 245
Testosterone Stimulates Angiogenesis and Vascular Regrowth in the Ventral Prostate in Castrated Adult Rats
Lissbrant, I. F., Rudolfsson, S. H., Damber, J., & Bergh, A. (1998) · Endocrinology · doi:10.1210/endo.139.2.5683 · Cited by 243
STEM CELL FEATURES OF BENIGN AND MALIGNANT PROSTATE EPITHELIAL CELLS
Marzo, A. M. D., Nelson, W. G., Meeker, A. K., & Coffey, D. S. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62196-7 · Cited by 239
Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.
Burfeind, P., Chernicky, C. L., Rininsland, F. H., Ilan, J., & Ilan, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7263 · Cited by 235
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
Nickerson, T., Chang, F., Lorimer, D., Smeekens, S. P., Sawyers, C. L., & Pollak, M. (2001) · PubMed · Cited by 230
Growth factor involvement in progression of prostate cancer
Russell, P. J., Bennett, S., & Stricker, P. D. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.4.705 · Cited by 223
Production of transforming growth factors by human colon cancer lines.
Coffey, R. J., Shipley, G. D., & Moses, H. L. (1986) · PubMed · Cited by 222
Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer
Abreu-Martin, M. T., Chari, A., Palladino, A., Craft, N. A., & Sawyers, C. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.5143 · Cited by 216
Hormones and Prostate Cancer: What's Next?
Hsing, A. W. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000795 · Cited by 211
Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph, I. B. J., Nelson, J. B., Denmeade, S. R., & Isaacs, J. T. (1997) · PubMed · Cited by 211
Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
Henshall, S. M., Quinn, D. I., Lee, C. S., Head, D. R., Golovsky, D., Brenner, P. C., Delprado, W., Stricker, P. D., Grygiel, J. J., & Sutherland, R. L. (2001) · PubMed · Cited by 208
Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells
Fulda, S., Jeremias, I., Steiner, H. H., Pietsch, T., & Debatin, K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990730)82:3 · Cited by 205
Enhanced Paracrine FGF10 Expression Promotes Formation of Multifocal Prostate Adenocarcinoma and an Increase in Epithelial Androgen Receptor
Memarzadeh, S., Xin, L., Mulholland, D. J., Mansukhani, A., Wu, H., Teitell, M. A., & Witte, O. N. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.002 · Cited by 201
The Androgen Receptor Represses Transforming Growth Factor-β Signaling through Interaction with Smad3
Chipuk, J. E., Cornelius, S. C., Pultz, N. J., Jorgensen, J. S., Bonham, M. J., Kim, S., & Danielpour, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108855200 · Cited by 200
SMAD3 represses androgen receptor-mediated transcription.
Hayes, S. A., Zarnegar, M. A., Sharma, M., Yang, F., Peehl, D. M., ten Dijke, P., & Sun, Z. (2001) · PubMed · Cited by 192
Insulin-like Growth Factor 1/Insulin Signaling Activates Androgen Signaling through Direct Interactions of Foxo1 with Androgen Receptor
Fan, W., Yanase, T., Morinaga, H., Okabe, T., Nomura, M., Daitoku, H., Fukamizu, A., Kato, S., Takayanagi, R., & Nawata, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610447200 · Cited by 189
Smooth Muscle-Epithelial Interactions in Normal and Neoplastic Prostatic Development
Cunha, G. R., Hayward, S. W., Dahiya, R., & Foster, B. A. (1996) · Cells Tissues Organs · doi:10.1159/000147791 · Cited by 189
Epidermal Growth Factor Receptor Overexpression Results in Increased Tumor Cell Motility In vivo Coordinately with Enhanced Intravasation and Metastasis
Xue, C., Wyckoff, J. B., Liang, F., Sidani, M., Violini, S., Tsai, K.-L., Zhang, Z., Sahai, E. A., Condeelis, J. S., & Segall, J. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1242 · Cited by 189
Membrane Recognition and Targeting by Lipid-Binding Domains
DiNitto, J. P., Cronin, T. C., & Lambright, D. G. (2003) · Science s STKE · doi:10.1126/stke.2132003re16 · Cited by 182
Structure of the IGF‐binding domain of the insulin‐like growth factor‐binding protein‐5 (IGFBP‐5): implications for IGF and IGF‐I receptor interactions
Kalus, W., Zweckstetter, M., Renner, C., Sanchez, Y., Georgescu, J., Grol, M., Demuth, D. G., Schumacher, R., Dony, C., Lang, K., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6558 · Cited by 180
Insulin-like Growth Factors and Prostate Cancer
Pollak, M., Beamer, W., & Zhang, J. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006154108619 · Cited by 179
The Androgen Receptor Is Significantly Associated with Vascular Endothelial Growth Factor and Hypoxia Sensing via Hypoxia-Inducible Factors HIF-1a, HIF-2a, and the Prolyl Hydroxylases in Human Prostate Cancer
Boddy, J., Fox, S. B., Cheng, H., Campo, L., Turley, H., Kanga, S., Malone, P. R., & Harris, A. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0460 · Cited by 166
Fibroblast Growth Factors
Heath, J. K. (2002) · Encyclopedia of Molecular Biology · doi:10.1002/047120918x.emb0532 · Cited by 154
Growth Factor-Induced Cell Motility in Tumor Invasion
Wells, A. H., Kassis, J. N., Solava, J., Turner, T., & Lauffenburger, D. A. (2002) · Acta Oncologica · doi:10.1080/028418602753669481 · Cited by 139
Insulin-like growth factors and prostate cancer
Djavan, B., Waldert, M., Seitz, C., & Marberger, M. (2001) · World Journal of Urology · doi:10.1007/s003450100220 · Cited by 137
Identification of Androgen Response Elements in the Insulin-Like Growth Factor I Upstream Promoter
Wu, Y., Zhao, W., Zhao, J., Pan, J., Wu, Q., Zhang, Y., Bauman, W. A., & Cardozo, C. P. (2007) · Endocrinology · doi:10.1210/en.2006-1653 · Cited by 117
Peptide growth factors in the prostate as mediators of stromal epithelial interaction
Byrne, R. L., Leung, H. Y., & Neal, D. E. (1996) · British Journal of Urology · doi:10.1046/j.1464-410x.1996.09721.x · Cited by 116
Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4
Kang, H., Huang, K., Chang, S., Ma, W., Lin, W., & Chang, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205603200 · Cited by 112
Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts
Levine, A. C., Liu, X., Greenberg, P. D., Eliashvili, M., Schiff, J. D., Aaronson, S. A., Holland, J. F., & Kirschenbaum, A. M. (1998) · Endocrinology · doi:10.1210/endo.139.11.6303 · Cited by 110
Androgen receptor expression is regulated by the phosphoinositide 3-kinase/Akt pathway in normal and tumoral epithelial cells
Manin, M., Baron, S., Goossens, K., Beaudoin, C., Jean, C., VEYSSIERE, G., Verhoeven, G., & Morel, L. (2002) · Biochemical Journal · doi:10.1042/bj20020585 · Cited by 107
Prohibitin and Cofilin Are Intracellular Effectors of Transforming Growth Factor β Signaling in Human Prostate Cancer Cells
Zhu, B., Fukada, K., Zhu, H., & Kyprianou, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1443 · Cited by 106
Self-citation
Co‐inoculation of tumorigenic rat prostate mesenchymal cells with non‐tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals
Chung, L. W. K., Chang, S., Bell, C., Zhau, H. E., Ro, J. Y., & von Eschenbach, A. C. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430636 · Cited by 102
ADENOCARCINOMA OF PROSTATE IN 40-YEAR-OLD BODY-BUILDER
Roberts, J. A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90251-5 · Cited by 99
The Development of a Male Pseudohermaphroditic Rat Using an Inhibitor of the Enzyme 5α-Reductase*
Imperato‐McGinley, J., BINIENDA, Z. K., Arthur, A. B., Mininberg, D. T., Vaughan, E. D., & Quimby, F. W. (1985) · Endocrinology · doi:10.1210/endo-116-2-807 · Cited by 99
Inhibition of HER-2/neu Kinase Impairs Androgen Receptor Recruitment to the Androgen Responsive Enhancer
Liu, Y., Majumder, S., McCall, W., Sartor, C. I., Mohler, J. L., Gregory, C. W., Earp, H. S., & Whang, Y. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4292 · Cited by 99
Reciprocal mesenchymal-epithelial interaction affecting prostate tumour growth and hormonal responsiveness.
Chung, L. W. K., Gleave, M. E., Hsieh, J., Hong, S.-J., & Zhau, H. E. (1991) · PubMed · Cited by 96
Proliferation and differentiation of prostatic stromal cells
Niu, Y., Xu, Y., Zhang, J., Bai, J., Yang, H., & Ma, T. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.00103.x · Cited by 78
Novel Function of Androgen Receptor-associated Protein 55/Hic-5 as a Negative Regulator of Smad3 Signaling
Wang, H., Song, K. W., Sponseller, T. L., & Danielpour, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411575200 · Cited by 77
Traction Forces Mediated by α6β4 Integrin: Implications for Basement Membrane Organization and Tumor Invasion
Rabinovitz, I., Gipson, I. K., & Mercurio, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.12.4030 · Cited by 74
Transforming Growth Factor Beta and Prostate Cancer
Zhu, B., & Kyprianou, N. (2005) · Cancer treatment and research · doi:10.1007/0-387-24361-5_7 · Cited by 68
Self-citation
Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes
Freeman, M. R., Cinar, B., Kim, J., Mukhopadhyay, N. K., Vizio, D. D., Adam, R. M., & Solomon, K. R. (2006) · Steroids · doi:10.1016/j.steroids.2006.11.012 · Cited by 68
Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines
Orio, F., Térouanne, B., Georget, V., Lumbroso, S., Avancès, C., Siatka, C., & Sultan, C. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00374-x · Cited by 66
EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen‐sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR)
Bonaccorsi, L., Carloni, V., Muratori, M., Formigli, L., Zecchi, S., Forti, G., & Baldi, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.20362 · Cited by 64
Targeted treatment of prostate cancer
Wang, X., Yin, L., Rao, P., Stein, R. J., Harsch, K. M., Lee, Z., & Heston, W. D. W. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21491 · Cited by 64
Dihydrotestosterone Enhances Transforming Growth Factor-β-Induced Apoptosis in Hormone-Sensitive Prostate Cancer Cells*
Bruckheimer, E. M., & Kyprianou, N. (2001) · Endocrinology · doi:10.1210/endo.142.6.8218 · Cited by 61
Self-citation
Gefitinib (?IRESSA?, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3�K/AKT activation
Bonaccorsi, L., Marchiani, S., Muratori, M., Forti, G., & Baldi, E. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0581-8 · Cited by 58
Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation
Léotoing, L., Manin, M., Monté, D., Baron, S., Communal, Y., Lours-Calet, C., VEYSSIERE, G., Morel, L., & Beaudoin, C. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0021 · Cited by 57
Testosterone regulates FGF‐2 expression during testis maturation by an IRES‐dependent translational mechanism
González-Herrera, I. G., Prado-Lourenço, L., Pileur, F., Conte, C., Morin, A., Cabon, F., Prats, H., Vagner, S., Bayard, F., Audigier, S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.04-3314fje · Cited by 56
Castration‐induced epithelial cell death in human prostate tissue is related to locally reduced IGF‐1 levels
Ohlson, N., Bergh, A. R. J., Stattin, P. E., & Wikström, P. (2006) · The Prostate · doi:10.1002/pros.20480 · Cited by 55
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines
Festuccia, C., Muzi, P., Millimaggi, D., Biordi, L. A., Gravina, G. L., Speca, S., Angelucci, A., Dolo, V., Vicentini, C., & Bologna, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00986 · Cited by 54
Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF‐β1
Gerdes, M. J., Larsen, M., Dang, T. D., Ressler, S. J., Tuxhorn, J. A., & Rowley, D. R. (2003) · The Prostate · doi:10.1002/pros.10327 · Cited by 53
Genetic and epigenetic influences in prostatic carcinogenesis (review).
Hayward, S. W., Grossfeld, G. D., Tlsty, T. D., & Cunha, G. R. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.1.35 · Cited by 53
TGF‐β signaling and androgen receptor status determine apoptotic cross‐talk in human prostate cancer cells
Zhu, M., Partin, J. V., Bruckheimer, E. M., Strup, S. E., & Kyprianou, N. (2007) · The Prostate · doi:10.1002/pros.20698 · Cited by 53
Self-citation
STEM CELL FEATURES OF BENIGN AND MALIGNANT PROSTATE EPITHELIAL CELLS
Marzo, A. M. D., Nelson, W. G., Meeker, A. K., et al. (1998) · The Journal of Urology · doi:10.1097/00005392-199812020-00004 · Cited by 53
Role of vascular endothelial growth factor in prostate cancer
Delongchamps, N. B., Peyromaure, M., & Dinh‐Xuan, A. T. (2006) · Urology · doi:10.1016/j.urology.2006.03.010 · Cited by 52
Androgen-Stimulated Human Prostate Epithelial Growth Mediated by Stromal-Derived Fibroblast Growth Factor-10.
Nakano, K., Fukabori, Y., Itoh, N., Lu, W., Kan, M., McKeehan, W. L., & Yamanaka, H. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.405 · Cited by 51
Transforming growth factor-beta expression in prostate neoplasia.
Cardillo, M. R., Petrangeli, E., Perracchio, L., Salvatori, L., Ravenna, L., & Silverio, F. D. (2000) · PubMed · Cited by 50
Neutralizing VEGF bioactivity with a soluble chimeric VEGF‐receptor protein flt(1‐3)IgG inhibits testosterone‐stimulated prostate growth in castrated mice
Lissbrant, I. F., Hammarsten, P., Lissbrant, E., Ferrara, N., Rudolfsson, S. H., & Bergh, A. R. J. (2003) · The Prostate · doi:10.1002/pros.10312 · Cited by 49
Androgen receptor expression induces FGF2, FGF‐binding protein production, and FGF2 release in prostate carcinoma cells: Role of FGF2 in growth, survival, and androgen receptor down‐modulation
Rosini, P., Bonaccorsi, L., Baldi, E., Chiasserini, C., Forti, G., Chiara, G. D., Lucibello, M., Mongiat, M., Iozzo, R. V., Garaci, E., et al. (2002) · The Prostate · doi:10.1002/pros.10164 · Cited by 47
Direct activation of TGF‐β1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice
Yoon, G., Kim, J. Y., Choi, Y., Won, Y. S., & Lim, I. K. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20638 · Cited by 47
An androgen-IL-6-Stat3 autocrine loop re-routes EGF signal in prostate cancer cells.
Aaronson, D. S., Muller, M., Neves, S. R., Chung, W.-C., Jayaram, G., Iyengar, R., & Ram, P. T. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.02.006 · Cited by 47
Transforming Growth Factor-β1 Induces Nuclear to Cytoplasmic Distribution of Androgen Receptor and Inhibits Androgen Response in Prostate Smooth Muscle Cells1
Gerdes, M. J., Dang, T. D., Larsen, M., & Rowley, D. R. (1998) · Endocrinology · doi:10.1210/endo.139.8.6138 · Cited by 46
ErbB1 and prostate cancer: ErbB1 activity is essential for androgen‐induced proliferation and protection from the apoptotic effects of LY294002
Tørring, N., Dagnæs‐Hansen, F., Sørensen, B. S., Nexø, E., & Hynes, N. E. (2003) · The Prostate · doi:10.1002/pros.10245 · Cited by 45
Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines
Bonaccorsi, L., Nosi, D., Muratori, M., Formigli, L., Forti, G., & Baldi, E. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02155 · Cited by 43
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxia
Banham, A. H., Boddy, J., Launchbury, R., Han, C., Turley, H., Malone, P. R., Harris, A. L., & Fox, S. B. (2007) · The Prostate · doi:10.1002/pros.20583 · Cited by 41
RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation
Rinaldo, F. M., Li, J., Wang, E., Muders, M. H., & Datta, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209971 · Cited by 41
Androgens Induce the Expression of Vascular Endothelial Growth Factor in Human Fetal Prostatic Fibroblasts
Levine, A. C. (1998) · Endocrinology · doi:10.1210/en.139.11.4672 · Cited by 41
Mesenchymal-Epithelial Interactions in the Growth and Development of the Prostate
Cunha, G. R., & Donjacour, A. A. (1989) · Cancer treatment and research · doi:10.1007/978-1-4613-1595-7_9 · Cited by 39
AKT1/PKBα is recruited to lipid rafts and activated downstream of PKC isotypes in CD3‐induced T cell signaling
Bauer, B., Jenny, M., Fresser, F., Überall, F., & Baier, G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00287-4 · Cited by 35
bcl‐2 antagonizes the combined apoptotic effect of transforming growth factor‐β and dihydrotestosterone in prostate cancer cells
Bruckheimer, E. M., & Kyprianou, N. (2002) · The Prostate · doi:10.1002/pros.10143 · Cited by 29
Self-citation
In vitro androgenic induction of a major protein in epithelial cell subcultures from mouse vas deferens
Manin, M., VEYSSIERE, G., Cheyvialle, D., Chevalier, M., Lecher, P., & Jean, C. (1992) · Endocrinology · doi:10.1210/endo.131.5.1385102 · Cited by 29
Acquisition of Androgen‐Mediated Expression of Mouse Vas Deferens Protein (MVDP) Gene in Cultured Epithelial Cells and in Vas Deferens During Postnatal Development
Manin, M., Martinez, A., van der SCHUEREN, B., Reynaert, I., & Jean, C. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb02131.x · Cited by 16
Androgen regulation of prostate cancer cell FGF-1, FGF-2, and FGF-8: Preferential down-regulation of FGF-2 transcripts
ScarSari, T., & Shain, S. A. (1998) · Growth Factors · doi:10.3109/08977199809017492 · Cited by 16
Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy
Anastasiadis, A. G., Bemis, D. L., Stisser, B. C., Salomon, L., Ghafar, M. A. A., & Buttyan, R. (2003) · Current Drug Targets · doi:10.2174/1389450033491136 · Cited by 15
IGF Binding Protein-5 Synthesis is Regulated by Testosterone through Transcriptional Mechanisms in Androgen Responsive Cells
Yoshizawa, A., & Ogikubo, S. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-017 · Cited by 9
Testosterone regulates FGF‐2 expression during testis maturation by an IRES‐dependent translational mechanism
(2006) · The FASEB Journal · doi:10.1096/fasebj.20.9.1573 · Cited by 3

Flagged first, then by citations

Sorted by citations

Androgen receptor signaling in prostate cancer development and progression
Tindall, D. J., & Lonergan, P. E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 544
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Shafi, A. A., Yen, A. E., & Weigel, N. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.003 · Cited by 435
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
Menden, M. P., Wang, D. Y. Q., Mason, M. J., Szalai, B., Bulusu, K. C., Guan, Y., Yu, T. V., Kang, J., Jeon, M., Wolfinger, R. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09799-2 · Cited by 371
Inflammation and prostate cancer: the role of interleukin 6 ( IL ‐6)
Nguyen, D. P., Li, J., & Tewari, A. K. (2013) · British Journal of Urology · doi:10.1111/bju.12452 · Cited by 357
Drug resistance in metastatic castration-resistant prostate cancer
Šeruga, B., Ocaña, A., & Tannock, I. F. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.136 · Cited by 346

See all 288

Authors: Zhu, M.-L., & Kyprianou, N.
Affiliations: University of Kentucky HealthCare (US)
ORCID: Zhu, M.-L.
Kyprianou, N.
Venue: Endocrine Related Cancer
Publisher: Bioscientifica
Published: 2008-09-10
Volume: 15
Issue: 4
Pages: 841-849
ISSN: 1351-0088 (ISSN-L)
1479-6821
DOI: 10.1677/erc-08-0084
PMC: PMC2740735
OpenAlex: W2167609397
Cited by: 286
References: 105
Citations by year: 2026: 3 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 12 · 2021: 16 · 2020: 9 · 2019: 15 · 2018: 13 · 2017: 17 · 2016: 18 · 2015: 23 · 2014: 10 · 2013: 29 · 2012: 17
FWCI: 3.48
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Endocrine Related Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK-53525-08, R01DK053525)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords: androgen receptor, growth factor signaling, signaling crosstalk, prostate cancer, castration-resistant prostate cancer, metastatic prostate cancer, epidermal growth factor, fibroblast growth factor, insulin-like growth factor I, vascular endothelial growth factor, TGF-beta, cell cycle regulation, apoptosis, therapeutic target
MeSH terms: Animals, Humans, Male, Prostatic Neoplasms, Receptors, Androgen, Signal Transduction, Gene Expression Regulation, Neoplastic, Receptor Cross-Talk, Intercellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks